Introduction
Brain stroke, growing incident, is the third major reason for mortality in the developed country. [1] [2] [3] Although there are some treatments for stroke; the patients' neurological outcomes remain poor and the most of them are permanently paralyzed. [4] Nowadays,
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. occurs frequently (40-80%), this risk is higher in old ages and females. [7] Therefore, fi nding a suitable way such as prophylactic treatment for stroke could reduce the complications which caused by brain stroke. In stroke pathogenesis, infl ammation plays an important role that caused by secreting some cytokines including tumor necrosis factor-α (TNF-α), interleukin-8 (IL-8), and expression some adhesion molecules such as intercellular adhesion molecule, vascular cell adhesion molecule-1, and selectins. [8] [9] [10] Recently, cell therapy has opened a new attractive and hopeful window for treating brain stroke. Mesenchymal stem cells (MSCs), an available source of adult stem cell, have been used in different studies due to their anti-inflammatory effects by secreting transforming growth factor-β, and IL-10, etc., [11] [12] [13] and neuroprotective effects by secreting vascular endothelial growth factor (VEGF), nerve growth factor, brain-derived neurotrophic factor (BDNF), cerebral dopamine neurotrophic factor, glial cell line-derived neurotrophic factor. [14] Neural stem cells (NSCs) are a type of stem cells that could be isolated from different areas in central nervous system (CNS) such as subventricular zone, hypothalamus, etc., and differentiated to three neural lineages containing neurons, astrocytes, and oligodendrocytes. [15] Furthermore, NSCs have been transplanted for treating ischemic stroke and the results show they have improved neurological function and reduced brain lesion via the capability of immunomodulatory, trophic, and regeneration. [16] [17] [18] According to mentioned above, we tested the preventive effects of NSCs and MSCs that injected stereotactically into the lateral ventricle of the middle cerebral artery occlusion (MCAO) model Sprague-Dawley male rats. There are some previous studies which used NSCs and MSCs but they did not find out these stem cells preventive effects on brain stroke and we have decided to distinguish their preventive effects in this study.
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Materials and Methods
All procedures were approved by the Shiraz University of Medical Sciences Ethical committee.
Rat neural stem cells isolation and expansion
The 14-day rat embryo was provided and the ganglion eminence was dissected carefully, then the culture media (Dulbecco's modified Eagle's medium [DMEM]/F12, 2% B27, 1% pen/strep, basic fi broblast growth factor [bFGF] 10 ng/ml, and epidermal growth factor 20 ng/ml) was added to the plate. The tissue was digested mechanically. After that the cells were counted by Neubauer chamber and 250,000 cells were cultured in T-25 cm 2 flask containing 5 ml culture media. After 1-week, NSCs marker, Nestin (Millipore MAB353A4, 1:100), was assessed for the cultured NSCs. After 5 days, some sphere formed in the T-25 cm 2 called as neurospheres. The cells were incubated in 37°C, 5% CO 2 , and 95% humidity. For neurospheres passaging, fi rst, the spheres were collected and centrifuged at 110 g for 5 min, and then 1 ml of trypsin 0.05% (Gibco) was added for three. After the duration trypsin inhibitor (Gibco) was added to neutralize the trypsin. For the next step, the cells were centrifuged at 110 g for 5 min and the enzymes were removed, the provided single cells were cultured in T-25 cm 2 with density 50,000 cells/ml [ Figure 1 ]. [19] Diff erentiation of neural stem cells
The most important feature of NSCs is their ability to provide three neural lineages containing neurons, oligodendrocytes, and astrocytes. To differentiate the NSCs into these neural lineages, the single cells were cultured on poly-ornithine coated plates (50,000 cells/ml), then the differentiation media (DMEM/F12, 2%B27, 1% pen/strep, and 5% fetal bovine serum) was added to the plates and the cultured cells were incubated for 2 days in 37°C, 5% CO 2 , and 95% humidity [ Figure 2 ].
Immunocytochemistry was performed for neurons with β-tubulin ІІІ antibody (PromegaG7121, 1:2000) and for astrocyte with glial fi brillary acidic protein antibody (DakoCytomation, Code No. Z0334 1:500) [ Figure 3 ], briefl y, the primary antibody was added to the fi xed cells and kept for 1 hour at room temperature, after 1 hour the slides were washed 3 times with PBS. After washing the cells the secondary antibody was added and the slides were incubated for 1 hour at room temperature.
Bone marrow mesenchymal stem cell isolation and characterization
All procedures were supervised and confi rmed by Shiraz University of Medical Sciences Ethical Committee. To isolate bone marrow MSCs, adult Sprague-Dawley rats weighing 250-300 g were used, they were killed and their tibia and femurs were excised under sterile condition and they were fl ashed with MSC culture media (DMEM, 10% fetal bovine serum, and 1% pen/strep), the suspension was transferred to T-25 cm 2 fl ask. The cells were incubated in 37°C, 5% CO 2 , and 95% humidity. After 2 days, the media was changed with the fresh one and after 10 days the fl asks confl uence almost 80% with the MSCs. [20] To confi rm the stemness feature of the isolated cells, they were differentiated into osteocyte and adipocyte by Miltenyi Biotech differentiation Medias. The osteogenic and adipogenic differentiation were confi rmed by Alizarin Red and Oil Red staining [ Figures 4 and 5] .
Animal preparation
All procedures were approved by ethical committee of Shiraz University of Medical Sciences. Sixty (n = 60) adult Sprague-Dawley rats were randomly selected and divided into four groups. The fi rst one is the shamoperated group, the second one is the control group received 200 λL phosphate buffered saline stereotactic injection in their right side of lateral ventricles 1-day before MCAO, the third one received 2 × 10 5 NSCs stereotactical injection in their right side of lateral ventricles 1-day before MCAO, and the fourth one received 2 × 10 5 MSCs stereotactical injection in their right side of lateral ventricles 1-day before MCAO.
Middle cerebral artery occlusion
The rats were anesthetized by halothane (5% induction and 1.5% for maintenance) in the mixture of NO 2 and O 2 (1:1). MCAO induction was performed according to Koizumi's method. Briefl y, a vertical incision was excised in the midline of the neck and the connective tissues, and muscles were dissected gently till the carotid sheath was observed, the sheath was removed, and carotid artery was separated from vagus nerve, then two loose sutures were prepared in common carotid artery and the external carotid artery was clamped, then a small incision was excised between the sutures and a silicon coated 4.0 nylon with round tip was passed through the common carotid artery till occlusion of middle cerebral artery occurred, after 45 min the 4.0 nylon was removed and the sutures were tighten up. [21] 
Neurological function assessment
Neurological examinations were performed every 2 days for all rats during 28 days of experiment. The neurological examination was scored on six-score scale. The scores are described as below: [18, 22] Score of 0: No neurological defi cit. Score of 1: Failure to extend left forepaw completely. It shows mild focal neurological defi cit. 
Histology
After 28 days, the rats were anesthetized with halothane and were fi xed with normal saline followed paraformaldehyde 4%; cryosections (10 μm) were mounted on silicon coated slides and stained with hematoxylin and eosin.
Stem cells labeling with PKH26-GL
The fl uorescent membrane dye, PKH26-GL, was used to label the bone marrow derived MSCs and NSCs for tracking the cell in the rats' brain. Briefl y, the cells were trypsinized and resuspended in diluents C with concentration 2 × 10 7 cells/ml and then equal volume of PKH dye in diluents C was added to cell suspension to achieve 10 μM dye concentration, after 10 min incubation in 37°C the labeling process was stopped by adding equal volume of fetal bovine serum and washing with complete media three times.
Apoptosis evaluation with measurement of caspase-3 activity
Activation of IL-1β converting enzyme family proteases/ caspases initiates apoptosis in mammalian cells. This evaluation is based on spectrophotometric detection of chromophore p-nitroaniline (p-NA) after cleavage from labeled substrate DEVD-p-NA. The p-NA light emission could be measured by using spectrophotometer at 400-405 nm. For this assay, caspase-3 assay kit was bought from Abcam Company (ab39401).
Stereotactic injection of stem cells
The animals were anesthetized with halothane (induction 5% and maintenance 1%) and fi xed to the stereotactical frame, the labeled MSCs and NSCs were injected into right lateral ventricle at: Anterioposterior = -0.12 mm, mediolateral = 1.6 mm, dorsoventricular = 4.3 mm. Each rat received 200,000 MSCs and 200,000 NSCs in its right lateral ventricle.
Statistical analysis
Data were analyzed statistically using SPSS 16.00 (IBM Company) statistical software and expressed as the mean ± standard deviation. Differences between different groups were as compared by using one-way ANOVA test. P < 0.05 is considered statistically signifi cant differences.
Results
Brain lesion evaluation by hematoxylin and eosin staining
The coronal sections were selected with 1 mm interval and it began from 2 mm posterior to frontal tip, damaged area was determined by some ischemic signs such as eosinophilic cytoplasm and pyknotic nuclei. The lesion volume in control group was 197.88 ± 11.98 mm 3 , in MSCs injected group was 30.73 ± 3.90 mm 3 , and in NSCs injected group was 46.63 ± 6.14 mm 3 , there are signifi cant differences between control group and two other groups (P < 0.05) [ Figure 6 ].
Neurological scores
All rats were examined every 2 days till 28 days after MCAO, according to previously described scale. The neurological scores for control group was 4.48 ± 0.24, for MSCs injected group was 2.62 ± 0.29, and for NSCs injected group was 2.67 ± 0.32, and they were different signifi cantly (P ≤ 0.05) [ Figure 7 ]. 
Stem cell tracking
PKH26-GL labeling represents that some stem cells in both groups (MSCs and NSCs injected) migrate to upper zones of the brain such as cortex, striatum, and corpus callosum [ Figure 8 ].
Caspase-3 activity assay
MSCs and NSCs are capable to reduce apoptosis by down regulating some apoptotic genes such as caspase-3. Caspase-3 activity was evaluated by spectrophotometer, for control group it was 1.03 ± 0.08, for NSCs injected 0.75 ± 0.05, and for MSCs injected group it was 0.50 ± 0.06. The data indicates signifi cant difference between each two groups (P ≤ 0.05), as it shows MSCs could reduce apoptosis more than two other groups [ Figures 9 and 10 ].
Discussion
Our study represents that both NSCs and MSCs intra-ventricular injection before MCAO could make neurological disability less and provide more recovery after brain stroke; they can't provide full recovery, although.
Gu et al. in 2014, showed that one of the most contributing factors involved in pathogenesis of brain stroke is the excessive infl ammation and apoptosis and they could be diminished by MSCs injection through decreasing infl ammatory cytokines including TNF-α, IL-1β, p-IκB-α, P-IKKβ, p53, and MSCs injection could increase anti-apoptotic genes expression such as B-cell lymphoma-2. [23] Furthermore, MSCs display their immune modulatory ability by up regulating TNF-α stimulated gene/protein 6 expression and nuclear factor-κB which could exert an anti-infl ammatory effect by attenuating the infl ammatory cascade in activated microglia. [24] [25] [26] One more point in reducing infl ammation ability of MSCs, is the diminishing T-cell invasion and white matter injury by inducing persistent peripheral T-cell tolerance and it could be one of the causes of neuroprotective effects of MSCs. [25] Brain edema made by astrocyte apoptosis and impaired blood brain barrier, plays a major role in brain lesion after ischemia. Tang et al., have designed a study which they found out that MSCs injection might protect blood brain barrier and astrocyte apoptosis by decreasing aquaporin-4 expression through the P38 pathway. [27] Another effective MSCs' feature which makes better neurological function after brain ischemia is their neurotrophic cytokines secretion which helps neural regeneration and axonal growth, MSCs are capable to secret some neurotrophic cytokines such as VEGF, vascular endothelial growth factor receptor-3, BDNF, insulin-like growth factor-2, tyrosine hydroxylase, and hepatocyte growth factor. So that the microenvironment becomes more enrich and suitable for regeneration. [28, 29] Enhancing neural cells' expression of FGF-2 that is induced by MSCs could help them to have more growth, too. [30] NSCs are able to differentiate into neural lineages and have self-renewal ability. [31] The preischemic injection of them could have some effects on recovering brain ischemia by early increasing expressions of hypoxiainducible factor 1alpha and VEGF which could make up a microenvironment for enhancing the neural plasticity of endogenous NSCs. [32] Expressing VEGF could induce angiogenesis in addition to neurogenesis and help neural regeneration. [33] The NSCs seem to have some anti-infl ammatory and anti-apoptotic effects mediated by cyclooxygenase-2 regulation. [34] The infl ammation occurred after brain ischemia changes the NSCs committee and their gliogenicity would be decreased and they switched into neurogenesis and it could be a helpful change to regenerate CNS after brain ischemia. [35] Regarding all above, NSCs and MSCs could help providing better neurological outcome and less brain lesion like our results show. So that, both these stem cells could be a useful method for preventing brain ischemia's complications in some high risk conditions such as neurosurgical and cardiac surgical procedures. Although, both NSCs and MSCs have protective effects against brain ischemia, NSCs transplantation has less anti-apoptotic effect comparing to MSCs.
Conclusion
Since we are facing the growing incidence of brain ischemia and some of them are the complication of some surgeries, MSCs and NSCs might be useful to protect the CNS against it. However, it needs more investigations for confi rming this fi nding.
